Peptomyc SL - Company Review
Peptomyc SL - Company ReviewSummary
Peptomyc SL (Peptomyc) is a contract research organization focused on the development of cell penetrating peptides (CPPs) for cancer treatment. It is developing Omomyc peptide targeting the Myc oncoprotein into clinically viable therapeutics for the treatment of human cancers. The company uses Peptomyc technology and IP for the development of myc inhibitor. Peptomyc works in partnership with research institutions and financial consulting firms such as The Vall d´Hebron Institute of Oncology (VHIO), ICREA, HealthEquity, Antares Consulting SL and Vantum Corporate SL. The company is in pre-clinical development of Omomyc. Peptomyc is headquartered in Barcelona, Spain.
This comprehensive company report of Peptomyc SL provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.